Dr.
Krajden, Mel
BSc, MD (McG.), FRCPC
e-mail:
Academic Rank:
Professor, UBC, Medical Director, Public Health Serology, Provinical Health Services Laboratories, Director, BC Hepatitis Services, BC Centre for Disease Control, Laboratory Services, Associate Director, Laboratory Services, Head of Virology Section, BC Centre for Disease Control, Laboratory Services
Affiliation(s):
BC Centre for Disease Control
Location:
BC Centre for Disease Control
Short Bio
Dr. Mel Krajden is the medical director of the BCCDC Public Health Laboratory. He is also the medical head of hepatitis at BCCDC and is involved in the BC Hepatitis Testers Cohort.
Dr. Krajden earned his BSc and MD at McGill University (1973-80). He undertook internal medicine training at McGill University (1980-83). Afterwards, he did a fellowship in infectious diseases at Stanford University (1983-86) and completed a medical microbiology residency at the University of Toronto (1986-87).
Between 1991 and 1998, he was section head of virology and serology and an infectious diseases consultant at the Toronto Hospital (The University Health Network). In September 1998, he moved from Toronto to Vancouver, to BCCDC and UBC.
He is an adjunct scientist with Canadian Blood Services and a member of the Canadian Blood Services Scientific and Research Advisory Committee.
Academic Backgrounds
- BSc, McGill University, Microbiology & Immunology. 1976
- MD, McGill University. 1980
- Royal College of Physicians and Surgeons FRCP(C) in Medical Microbiology. Dec 1987
- Royal College of Physicians and Surgeons, Certificate of competency in Infectious Diseases. Dec 1986
- Royal College of Physicians and Surgeons in Internal medicine FRCPC. Jun 1984
Awards & Recognition
Current Openings & Opportunities
Current Projects In My Lab include
Research
Dr. Krajden’s clinical research involves the integration of hepatitis prevention and care services. His laboratory research involves the application of molecular techniques to diagnose viruses, assess correlates between infection and clinical disease, use molecular techniques to monitor antiviral efficacy and track microbial infections for epidemiological purposes. He also has extensive clinical trials expertise and serve as a laboratory coordinator of industry-sponsored clinical trials.
He has been involved in various types of research domain, including hepatitis, influenza, human papillomavirus, HIV, and molecular diagnostics and phylogenetics as well as the use of linked laboratory and administrative data to help understand how to measure population-level health outcomes for policymaking.